Timothy I Shaw, PhD, discusses the genetic heterogeneity between paired primary and metastatic solid tumors, as well as the implications for neoantigen-based personalized vaccines in cancer care.
Timothy I. Shaw, PhD
Advertisement
Timothy Shaw, PhD, of Moffitt Cancer Center
Articles by Timothy I. Shaw, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL
3
Dato-DXd Hits Key Secondary Efficacy End Points in First-Line TNBC
4
Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
5